Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1713936

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency: Accountability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how the Medicines and Healthcare products Regulatory Agency is held accountable for its decisions.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23760
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23761 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1713937

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is she taking to review the decisions of the Medicines and Healthcare products Regulatory Agency.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23761
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23760 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1713406

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her timetable is for the rollout of Endo Barriers on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	23480
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The implantation of a duodenal–jejunal bypass liner, also known as an endo barrier, for managing type 2 diabetes, is not recommended by the NICE, and therefore not available on the National Health Service. Current evidence on the safety and efficacy of the device for managing type 2 diabetes is limited in quality and quantity. For this reason, the NICE recommends that the procedure should only be done as part of a research study. Further information on the NICE guidelines is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations" target="_blank">https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations</a></p><p>The NICE may update the guidance, upon publication of further evidence. The NICE recommends that people with type 2 diabetes receive eight care processes at least annually, to support them to achieve three treatment targets to prevent diabetes related complications. The care processes include checks on blood glucose and body mass index, to support weight management. Delivery of all eight care processes is associated with reduced emergency admissions, amputations, and retinopathy. NHS England commissions two national lifestyle services to support adults with type 2 diabetes to manage their weight and improve their health and wellbeing. These are the NHS Digital Weight Management Programme and the NHS Type 2 Diabetes Path to Remission Programme. The NICE guidance for the care and management for adults with type 2 diabetes is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng28" target="_blank">https://www.nice.org.uk/guidance/ng28</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 16:33:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4131 label Biography information for Jim Shannon

1713407

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ambulance Services: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NHS England has issued a data privacy notice for ambulance services data to be part of the NHS Federated Data Platform product.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Sir David Davis
	uin	23378
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>NHS England has published an Ambulance Data Service dashboard, Federated Data Platform product privacy notice, which is available at the following link:</p><p><a href="https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/nhs-federated-data-platform-privacy-notice/fdp-products-and-product-privacy-notices/ambulance-data-services-ads-dashboard-fdp-product-privacy-notice/" target="_blank">https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/nhs-federated-data-platform-privacy-notice/fdp-products-and-product-privacy-notices/ambulance-data-services-ads-dashboard-fdp-product-privacy-notice/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 16:02:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	373 label Biography information for Sir David Davis

1713583

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: Cybercrime
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many times NHS trusts have been victims of ransomware attacks in the last 12 months; and whether (a) data has been (i) lost and (ii) made public and (b) a ransom has been paid in each case.
	tabling member constituency	East Yorkshire
	tabling member printed	Sir Greg Knight
	uin	23406
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>A small number of cyber-attacks against National Health Service hospitals have been made public, but the specific details on the number, nature, and subsectors of NHS organisations that have been victims of a ransomware attack in the last twelve months cannot be released, as it may prejudice the prevention or detection of cyber-attacks against the NHS.</p><p>Our around-the-clock cyber monitoring across over 1.5 million NHS computers allows us to identify that ransomware is the most significant cyber security threat currently facing the health and social care sector. Automated cyber defences and monitoring by NHS England’s Cyber Operations teams continuously deter, prevent, and disrupt attempts to break into the NHS’ IT systems. The NHS implements the Government’s policy of not condoning ransom payment.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:51:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1200 label Biography information for Sir Greg Knight

1713626

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Stepping Hill Hospital: Bowel Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the adequacy of (a) diagnosis and (b) treatment services for bowel cancer at Stepping Hill hospital.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	23605
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>No specific assessment has been made of the adequacy of diagnosis and treatment services for bowel cancer at Stepping Hill Hospital. However, data held at the provider level can give us insight into lower gastrointestinal (GI) cancer for Stockport NHS Foundation Trust. Of those patients referred to Stockport NHS Foundation Trust for suspected lower GI cancer in February 2024, 86.1% received a diagnosis or ruling out of cancer within 28 days. This is above the 75.0% standard, and shows an increase of 4.2% since January. Furthermore, of those patients referred to Stockport NHS Foundation Trust for lower GI cancer in February 2024, 95.2% received a first or subsequent treatment within 31 days of a decision to treat. This is above national performance of 91.1%, against the standard of 96.0%. For lower GI cancer in the same period, 67.4% of patients received treatment within 62 days of an urgent suspected cancer or screening referral, or consultant upgrade, to a first definitive treatment for cancer. This is above national performance of 63.9% against the standard of 85.0%.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 10:00:33 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1713634

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Colonoscopy: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average waiting time is to receive results from a colonoscopy in (a) Stepping Hill Hospital and (b) Greater Manchester.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	23613
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The data requested is not currently collected by either Stockport NHS Foundation Trust Stepping Hill Hospital, or by the Greater Manchester Integrated Care Board.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 16:03:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1713650

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what medications have been reimbursed to community pharmacies below the market price for pharmacy procurement in (a) 2021, (b) 2022, (c) 2023 and (d) 2024.
	tabling member constituency	Coventry North West
	tabling member printed	Taiwo Owatemi
	uin	23621
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The information requested is not held centrally. Community pharmacy reimbursement arrangements, set out in the Drug Tariff, are not designed to pay every individual pharmacy the cost, or more than the cost, of the medicine. This means that at an individual level, there will be instances where a pharmacy pays more than they are reimbursed, and other instances where they are paid less than they are reimbursed.</p><p>The medicine margin survey assesses the amount of medicine margin, the difference between the reimbursement price and the price the pharmacy was charged by the supplier, retained by community pharmacies. The survey has found that overall, more than the amount agreed as part of the Community Pharmacy Contractual Framework, has been delivered in total across the previous four financial years.</p><p>In addition to this, where a number of pharmacies cannot purchase at or below the Drug Tariff reimbursement price, the Department considers concessionary price requests that come directly from the Community Pharmacy England, on behalf of community pharmacies. From 1 April 2024, we introduced a new retrospective top-up payment for concessionary prices, providing an additional payment to contractors when the margin survey indicates that despite a concessionary price, there was an under payment.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:18:30 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4779 label Biography information for Taiwo Owatemi

1713701

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nurses: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of introducing a separate nursing pay spine on trends in the level of pay progression within the nursing profession.
	tabling member constituency	Bury South
	tabling member printed	Christian Wakeford
	uin	23663
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>The call for evidence in relation to a separate pay spine for nursing closed on 4 April 2024. A large volume of evidence was submitted, and analysis of this evidence remains underway. The Government will publish its formal response in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/04/2024 12:16:03 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4871 label Biography information for Christian Wakeford

1713705

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure parity between (a) clinical and (b) recently insourced nonclinical staff in the one-off covid bonus payment.
	tabling member constituency	Bury South
	tabling member printed	Christian Wakeford
	uin	23667
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The non-consolidated payments, agreed as part of the Agenda for Change pay deal, covered staff directly employed by National Health Service organisations, for instance staff on permanent and fixed term contracts, as set out in Annex 1 of the handbook on Agenda for Change terms as of 31 March 2023. Those who joined the NHS after 31 March 2023 were ineligible for the award, regardless of their profession.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:20:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4871 label Biography information for Christian Wakeford